Clinical trial
Phase I Trial of Intratumoral Injection of DTI-015 for Recurrent Malignant Gliomas
NCT00038441 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Trial of Intratumoral Injection of DTI-015 for Recurrent Malignant Gliomas
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 30, 1995
- Completion date
- August 31, 2005
- Enrollment
- 39 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.